Compare Stocks: HIMS, QXO, KLAC, TSLA, SKHY, and NVO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$31.58 +6.5%	$31.86	$13.74 ▼ $65.30	$6.87B	2.4	14.37 million shs	8.26 million shs
KLAC KLA	$198.11 +2.5%	$223.63	$83.22 ▼ $307.37	$252.40B	1.45	12.11 million shs	8.97 million shs
NVO Novo Nordisk A/S	$47.21 +2.7%	$47.00	$35.12 ▼ $64.16	$205.26B	0.76	12.38 million shs	12.07 million shs
QXO QXO	$16.17 +6.5%	$15.60	$13.18 ▼ $27.61	$15.75B	2.28	22.86 million shs	16.23 million shs
SKHY SK hynix	$137.91 -3.9%	$0.00	$124.80 ▼ $194.80	$1.02T	N/A	46.09 million shs	34.19 million shs
TSLA Tesla	$328.58 +2.8%	$378.76	$297.38 ▼ $498.83	$1.26T	1.83	39.09 million shs	39.33 million shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	+6.54%	+13.65%	-12.38%	+10.95%	-38.43%
KLAC KLA	+2.53%	+8.36%	-10.43%	+5.99%	+123.03%
NVO Novo Nordisk A/S	+2.84%	+0.01%	-3.39%	+2.58%	+4.18%
QXO QXO	+6.17%	+21.19%	+10.42%	-13.35%	-15.34%
SKHY SK hynix	-3.92%	-4.05%	+13,790,999,900.00%	+13,790,999,900.00%	+13,790,999,900.00%
TSLA Tesla	+2.83%	+5.58%	-16.63%	-23.29%	+2.71%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$31.58 +6.5%	$31.86	$13.74 ▼ $65.30	$6.87B	2.4	14.37 million shs	8.26 million shs
KLAC KLA	$198.11 +2.5%	$223.63	$83.22 ▼ $307.37	$252.40B	1.45	12.11 million shs	8.97 million shs
NVO Novo Nordisk A/S	$47.21 +2.7%	$47.00	$35.12 ▼ $64.16	$205.26B	0.76	12.38 million shs	12.07 million shs
QXO QXO	$16.17 +6.5%	$15.60	$13.18 ▼ $27.61	$15.75B	2.28	22.86 million shs	16.23 million shs
SKHY SK hynix	$137.91 -3.9%	$0.00	$124.80 ▼ $194.80	$1.02T	N/A	46.09 million shs	34.19 million shs
TSLA Tesla	$328.58 +2.8%	$378.76	$297.38 ▼ $498.83	$1.26T	1.83	39.09 million shs	39.33 million shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	+6.54%	+13.65%	-12.38%	+10.95%	-38.43%
KLAC KLA	+2.53%	+8.36%	-10.43%	+5.99%	+123.03%
NVO Novo Nordisk A/S	+2.84%	+0.01%	-3.39%	+2.58%	+4.18%
QXO QXO	+6.17%	+21.19%	+10.42%	-13.35%	-15.34%
SKHY SK hynix	-3.92%	-4.05%	+13,790,999,900.00%	+13,790,999,900.00%	+13,790,999,900.00%
TSLA Tesla	+2.83%	+5.58%	-16.63%	-23.29%	+2.71%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HIMS Hims & Hers Health	2.19	Hold	$31.43	-0.46% Downside
KLAC KLA	2.72	Moderate Buy	$223.70	12.92% Upside
NVO Novo Nordisk A/S	2.19	Hold	$65.81	39.42% Upside
QXO QXO	2.88	Moderate Buy	$29.71	83.82% Upside
SKHY SK hynix	3.17	Buy	$245.50	78.01% Upside
TSLA Tesla	2.42	Hold	$401.74	22.27% Upside

Current Analyst Ratings Breakdown

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/6/2026	NVO Novo Nordisk A/S	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform	$47.00
8/5/2026	NVO Novo Nordisk A/S	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/4/2026	SKHY SK hynix	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform
8/4/2026	SKHY SK hynix	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$200.00
8/4/2026	QXO QXO	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$35.00
8/4/2026	SKHY SK hynix	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
8/4/2026	SKHY SK hynix	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$200.00
8/4/2026	SKHY SK hynix	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$200.00
8/4/2026	SKHY SK hynix	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$320.00
8/4/2026	SKHY SK hynix	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$240.00
8/4/2026	SKHY SK hynix	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$300.00

(Data available from 8/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HIMS Hims & Hers Health	$2.35B	3.11	$0.89 per share	35.44	$2.38 per share	13.27
KLAC KLA	$13.58B	19.06	$3.95 per share	50.14	$4.86 per share	40.76
NVO Novo Nordisk A/S	$46.80B	4.50	$4.81 per share	9.81	$6.58 per share	7.17
QXO QXO	$6.84B	2.45	$1.11 per share	14.58	$12.82 per share	1.26
SKHY SK hynix	N/A	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	$94.83B	13.69	$2.74 per share	119.97	$22.15 per share	14.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HIMS Hims & Hers Health	$128.37M	-$0.09	N/A	60.73	83.47	-0.56%	6.10%	1.52%	8/10/2026 (Estimated)
KLAC KLA	$4.83B	$3.67	54.03	30.29	1.48	35.57%	87.66%	29.23%	N/A
NVO Novo Nordisk A/S	$15.51B	$4.09	11.54	14.22	4.16	35.36%	61.20%	21.49%	N/A
QXO QXO	-$279.40M	-$0.91	N/A	22.45	2.56	-6.02%	1.91%	1.02%	8/13/2026 (Estimated)
SKHY SK hynix	N/A	N/A	N/A	4.29	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	$3.79B	$1.08	304.24	238.10	15.86	3.67%	3.82%	2.27%	N/A

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	QXO QXO	$0.0786	N/A	N/A	N/A	$3.18 billion	N/A
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0490	N/A	N/A	N/A	$698.90 million	N/A
8/5/2026	Q2 2026	NVO Novo Nordisk A/S	$0.77	$0.96	+$0.19	$0.72	$10.89 billion	$11.98 billion
7/29/2026	Q2 2026	SKHY SK hynix	$5.12	$8.76	+$3.64	$8.76	$59.05 billion	$52.83 billion
7/28/2026	Q4 2026	KLAC KLA	$1.00	$1.05	+$0.05	$1.04	$3.61 billion	$3.66 billion
7/22/2026	Q2 2026	TSLA Tesla	$0.50	$0.33	-$0.17	$0.32	$26.42 billion	$28.24 billion
6/30/2026	Q2 2026	NVO Novo Nordisk A/S	N/A	$0.9440	N/A	$0.72	N/A	$11.98 billion
5/12/2026	Q1 2026	QXO QXO	-$0.09	-$0.12	-$0.03	-$0.35	$1.73 billion	$1.73 billion
5/11/2026	Q1 2026	HIMS Hims & Hers Health	$0.04	-$0.40	-$0.44	-$0.40	$616.84 million	$608.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
KLAC KLA	$0.92	0.46%	+17.32%	25.07%	16 Years
NVO Novo Nordisk A/S	$1.75	3.71%	+21.74%	42.79%	N/A
QXO QXO	N/A	N/A	N/A	N/A	N/A
SKHY SK hynix	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	N/A	N/A	N/A	N/A	N/A

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/6/2026	KLAC KLA	quarterly	$0.23	0.48%	8/17/2026	8/17/2026	9/1/2026
8/5/2026	NVO Novo Nordisk A/S		$0.5786	2.54%	8/17/2026	8/17/2026	8/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HIMS Hims & Hers Health	2.18	1.69	1.56
KLAC KLA	0.93	2.88	2.03
NVO Novo Nordisk A/S	0.59	0.79	0.56
QXO QXO	0.35	3.33	2.47
SKHY SK hynix	N/A	N/A	N/A
TSLA Tesla	0.09	1.94	1.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HIMS Hims & Hers Health	63.52%
KLAC KLA	86.65%
NVO Novo Nordisk A/S	11.54%
QXO QXO	58.68%
SKHY SK hynix	N/A
TSLA Tesla	66.20%

Insider Ownership

Company	Insider Ownership
HIMS Hims & Hers Health	11.76%
KLAC KLA	91.48%
NVO Novo Nordisk A/S	0.07%
QXO QXO	41.00%
SKHY SK hynix	N/A
TSLA Tesla	19.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HIMS Hims & Hers Health	2,442	231.46 million	204.24 million	Optionable
KLAC KLA	15,200	1.31 billion	111.30 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
QXO QXO	7,794	1.04 billion	612.11 million	Optionable
SKHY SK hynix	47,639	7.13 billion	N/A	N/A
TSLA Tesla	134,785	3.95 billion	3.16 billion	Optionable

HIMS, QXO, KLAC, TSLA, SKHY, and NVO Headlines

Recent News About These Companies

Elon Musk's Texas empire could soon include $10B Tesla solar plant in Fort Bend. Here's what to know

1 hour ago | houstonchronicle.comH

SpaceX and Tesla choose Texas for AI chip manufacturing plant that will be world's largest building

1 hour ago | foxbusiness.com

Tesla plans $10B solar cell factory near Houston

August 7 at 7:17 PM | msn.com

2 reasons Tesla could monopolize the US robotaxi market

August 7 at 7:17 PM | msn.com

Tesla (NASDAQ:TSLA) Trading Up 2.8% - What's Next?

August 7 at 5:19 PM | marketbeat.com

2 Reasons Tesla Could Monopolize the U.S. Robotaxi Market

August 7 at 4:30 PM | fool.com

Tesla Driver Using FSD Gets Speeding Ticket for 64 mph in a 45 Zone: ‘I Wasn’t Driving’

August 7 at 4:11 PM | benzinga.com

Tesla-SpaceX Terafab Bet: 4 Chip Equipment Stocks That Could Benefit

August 7 at 2:17 PM | finance.yahoo.com

Musk's SpaceX, Tesla to build $16.8B Terafab chip factory in Texas

August 7 at 2:17 PM | usatoday.com

Tesla-SpaceX Terafab Bet: 4 Chip Equipment Stocks That Could Benefit

August 7 at 1:56 PM | zacks.com

Tesla Stock (NASDAQ:TSLA) Gains as Superchargers to Hit EVgo Stations

August 7 at 1:10 PM | tipranks.com

Ford Drops Fathom EV — and It Undercuts Tesla’s Cybertruck by 2.5x

August 7 at 11:51 AM | benzinga.com

Ford Drops Fathom EV — and It Undercuts Tesla's Cybertruck by 2.5x

August 7 at 11:18 AM | benzinga.com

SpaceX's Terafab will rely on natural gas power plants, not Tesla solar panels

August 7 at 10:07 AM | techcrunch.comT

Tesla (TSLA) Stock Climbs Friday as Retail Investors Inject $372M Despite Earnings Miss

August 7 at 9:10 AM | blockonomi.com

Electric Vehicles Today - LiDAR Market Growth Driven By Automated Driving Systems

August 7 at 8:47 AM | finance.yahoo.com

SPCX Stock Hasn’t Bottomed Out Yet, But It’s ‘A Really Great Time To Buy,’ Says This Asset Manager

August 7 at 8:47 AM | stocktwits.comS

Paul Graham Says His Wife’s First Tesla FSD Experience Was Like a ‘Religious Revelation’— and AI Chief Ashok Elluswamy Had One Request When He Heard It

August 7 at 8:31 AM | benzinga.com

Tesla Stock Rises to End Good Week. Thank the Usual Suspects.

August 7 at 8:07 AM | barrons.com

Tesla-SpaceX merger would make situation 'even more confusing', says investor

August 7 at 7:00 AM | youtube.comY

Evanson Financial LLC Buys Shares of 8,989 Tesla, Inc. $TSLA

August 7 at 5:59 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, QXO, KLAC, TSLA, SKHY, and NVO Company Descriptions

Hims & Hers Health NYSE:HIMS

$31.58 +1.92 (+6.47%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$31.67 +0.09 (+0.28%)

As of 08/7/2026 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

KLA NASDAQ:KLAC

$198.11 +4.89 (+2.53%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$199.30 +1.19 (+0.60%)

As of 08/7/2026 08:00 PM Eastern

KLA Corporation, together with its subsidiaries, engages in the design, manufacture, and marketing of process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through three segments: Semiconductor Process Control; Specialty Semiconductor Process; and PCB and Component Inspection. The company offers inspection and review tools to identify, locate, characterize, review, and analyze defects on various surfaces of patterned and unpatterned wafers; metrology systems that are used to measure pattern dimensions, film thickness, film stress, layer-to-layer alignment, pattern placement, surface topography, and electro-optical properties for wafers; chemical process control equipment; wired and wireless sensor wafers and reticles; wafer defect inspection, review, and metrology systems; reticle inspection and metrology systems; and semiconductor software solutions that provide run-time process control, defect excursion identification, process corrections, and defect classification to accelerate yield learning rates and reduce production risk. It also provides etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, inkjet and additive printing, UV laser drilling, and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

Novo Nordisk A/S NYSE:NVO

$47.21 +1.24 (+2.69%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$47.20 -0.01 (-0.01%)

As of 08/7/2026 07:58 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

QXO NYSE:QXO

$16.16 +0.99 (+6.49%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$16.20 +0.04 (+0.22%)

As of 08/7/2026 07:58 PM Eastern

QXO, Inc. operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional, specialized programming, training, and technical support services. In addition, the company provides information technology managed services, such as cybersecurity, application hosting, disaster recovery, business continuity, cloud, and other services; and data back-up, network maintenance, and upgrade services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. QXO, Inc. is headquartered in Greenwich, Connecticut.

SK hynix NASDAQ:SKHY

$137.91 -5.62 (-3.92%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$138.15 +0.24 (+0.17%)

As of 08/7/2026 08:00 PM Eastern

We are one of the world’s largest memory semiconductor companies and engage in the design, manufacture and sale of advanced memory semiconductors. In the DRAM market that includes HBM, we were ranked second globally based on revenue with a market share of 29.1% in the first quarter of 2026, according to market research conducted by IDC. In the HBM market, we were ranked first globally based on revenue with a market share of 56.4% in the first quarter of 2026, according to IDC. In addition, we were the second largest supplier of NAND flash memory based on revenue, with a worldwide market share of 18.5% in the first quarter of 2026, according to IDC. Our memory products can be used in virtually all electronic devices, including graphics cards, personal computers (“PCs”), data center servers, mobile devices such as smartphones and tablets, and other consumer electronics products. We also conduct our foundry business through SK hynix system ic Inc. (“SK hynix system ic”) and SK keyfoundry Inc. (“SK keyfoundry”), our wholly-owned subsidiaries. We sell a wide variety of DRAM and NAND flash memory products with various configuration options, architectures and performance characteristics tailored to meet application- and customer-specific needs. We believe that we are one of the world’s leading companies in developing DRAMs with advanced specifications, particularly those requiring higher density, faster data-processing speed and lower power consumption. We are continually developing higher-density DRAM modules, SSDs and other advanced DRAM and NAND flash memory products that are optimized for our customers’ specific applications. In recent years, we have substantially increased our sales of HBMs. HBMs are advanced memory semiconductors designed to deliver fast data transfers while using less power, making them especially useful in high-performance applications such as GPUs, AI and high-performance computing. We have focused our sales and marketing activities in recent years on expanding our base of long-term strategic customers. We believe that our expertise and know-how in producing advanced memory semiconductors, strong long-term relationships with our key customers and state-of-the-art global production facilities in key strategic locations provide us with sustainable competitive advantages that will continue to differentiate us from our competitors and enable us to take advantage of attractive growth opportunities. We believe that we are a global leader in the HBM market with advanced production know-how and development of specific configurations that meet our customers’ demands. Our customers seek HBM suppliers with whom they can better align their own product development efforts and their strict quality standards often require HBM manufacturers to comply with rigorous testing and approval processes. We believe that our strengths in HBM, server DRAM and eSSD enable us to mitigate the risks associated with the cyclicality of the memory semiconductor market. We own and operate wafer fabrication facilities (“fabs”) in Icheon and Cheongju, Korea and Wuxi and Dalian, China. We also own and operate assembly and testing facilities for back-end processing of our products in Icheon and Cheongju, Korea and Chongqing, China. As part of our efforts to reduce unit manufacturing costs, improve manufacturing yields and enhance our profitability, we periodically phase out the operations of our older fabs or upgrade them to implement more advanced processing technologies. In addition to regular maintenance and enhancement of existing fabs, in October 2025, we opened the cleanroom of a new extension fab called “M15X” in Cheongju, which we plan to utilize to further increase our production capacity of next-generation DRAMs such as HBM. We began wafer input at the M15X in the first quarter of 2026 and expect to gradually ramp up our production volume. As part of our efforts to ensure our long-term competitiveness, we have also announced initiatives to construct an integrated industrial complex in Yongin, Korea for our next generation of fabs and research and development facilities. We began construction of our first fab at the Yongin complex in February 2025 with the phase 1 cleanroom of the first fab expected to open in the first quarter of 2027. We are currently constructing an advanced packaging plant called “P&T7” in Cheongju and expect to complete construction by the end of 2027. In December 2024, we also announced plans to build an advanced packaging plant in Indiana, United States, and expect to commence operations in the second half of 2028. In order to maintain our technological leadership, as well as to access new markets for our products, we engage in strategic initiatives, including making investments and acquisitions, from time to time. In October 2020, we agreed to acquire the NAND flash memory and storage business of Intel Corporation (“Intel”) (the “Intel NAND Business Acquisition”), including the NAND flash memory manufacturing facility in Dalian, China, NAND flash memory and SSD-related intellectual property and research and development personnel. As consideration for the Intel NAND Business Acquisition, we paid US$6.6 billion in December 2021 and US$2.2 billion in March 2025. We created a subsidiary in the United States to operate the acquired business under the brand name “Solidigm.” We also selectively acquire minority equity positions in other industry players to further strengthen our business relationships and acquire complementary businesses that we believe can further strengthen our leading position in the industry. Our principal executive offices are located in Korea.

Tesla NASDAQ:TSLA

$328.58 +9.05 (+2.83%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$328.98 +0.40 (+0.12%)

As of 08/7/2026 07:59 PM Eastern

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Earnings

Compare Dividends

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, QXO, KLAC, TSLA, SKHY, and NVO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, QXO, KLAC, TSLA, SKHY, and NVO Company Descriptions

Hims & Hers Health NYSE:HIMS

KLA NASDAQ:KLAC

Novo Nordisk A/S NYSE:NVO

QXO NYSE:QXO

SK hynix NASDAQ:SKHY

Tesla NASDAQ:TSLA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools